Treatment · August 8, 2026
Eli Lilly Expands Early Access to Retatrutide for Severely Obese Patients
Eli Lilly provides early access to an innovative weight loss drug for patients, offering hope before formal FDA approval....
Treatment · August 5, 2026
Experimental Triple G Drug Shows 28 Percent Weight Loss in New Trial
A new highly effective 'Triple G' weight loss drug offers patients a promising treatment option....
Treatment · June 24, 2026
Existing Drug Shows Promise for Preserving Muscle During GLP-1 Weight Loss
A new drug helps preserve muscle health in patients using GLP-1 weight-loss treatments, improving quality of life....
Treatment · June 12, 2026
UK Approves First Daily Pill Version of Weight-Loss Drug Wegovy
Weight-loss drug Wegovy becomes available in pill form in the UK, expanding patient access....
Treatment · May 21, 2026
Experimental Triple-Action Drug Retatrutide Matches Bariatric Surgery Weight Loss
Retatrutide clinical trial shows dramatic weight loss results, offering a promising new treatment option....
Prevention · May 9, 2026
Scientists Discover Fat Burning Protein Also Works Inside Cell Nucleus
New obesity research discovery could transform understanding and treatment of weight management for millions....
Research · March 22, 2026
Novel Obesity Target Identified Through Hibernation Biology and AI Platform
Fauna Bio reaches milestone in obesity treatment discovery through collaborative research efforts....